Johan Desmet

USPTO Granted Patents = 9 (Patent Applications = 14)

CIPO Patents = 3 (Patent Applications = 2)

EPO Patents = 10 (Patent Applications = 13)

Average Co-Inventor Count = 3.8

ph-index = 2

Forward Citations = 16(Granted Patents)

Company Filing History:

Years Active: 2010-2018

Loading Chart...

9 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10087249 - Alphabody libraries and methods for producing the same (2018-10-02),

2. 10023647 - Polypeptides capable of cellular internalization (2018-07-17),

3. 9701717 - Polypeptides specifically binding to IL-23 (2017-07-11),

4. 9315805 - Alphabody libraries and methods for producing the same (2016-04-19),

5. 9217011 - Non-natural proteinaceous scaffold made of three non-covalently associated peptides (2015-12-22),

6. 8571806 - Method for generating information related to the molecular structure of a biomolecule (2013-10-29),

7. 8538706 - Method for affinity scoring of peptide/protein complexes (2013-09-17),

8. 8229721 - Apparatus and method for structure-based prediction of amino acid sequences (2012-07-24),

9. 7702465 - Method, computing routine, device for predicting properties of MHC/peptide complexes, and data and peptides produced therefrom (2010-04-20),

As an AI assistant specializing in innovations, inventions, inventors, patent attorneys, assignees and patents, I can provide you with the article about inventor Johan Desmet.

Title: The Innovative Journey of Johan Desmet

Introduction: Johan Desmet, a prominent inventor based in Kortrijk, BE, has made significant contributions to the field of biotechnology with a total of 9 patents to his name. His groundbreaking work has revolutionized the development of Alphabody libraries and polypeptides capable of cellular internalization.

Latest Patents:

1. Alphabody libraries: Desmet's invention involves a single-chain Alphabody library comprising diverse single-chain Alphabody polypeptides. These polypeptides exhibit variations in specific amino acid residue positions, primarily located in the loop, helix surface, or linker region of the Alphabody. The invention also includes methods for utilizing these libraries effectively.

2. Polypeptides for cellular internalization: Desmet's innovation features polypeptides that can penetrate the cellular membrane and access the intracellular environment. These polypeptides have potential applications in prophylactic, therapeutic, and diagnostic settings, as well as in screening and detection assays. The invention encompasses nucleic acids encoding such polypeptides, methods for their preparation, and compositions for various medical purposes.

Career Highlights: Johan Desmet has made significant contributions during his tenure at Complix NV and Lonza Biologics Plc. His expertise and inventions have propelled advancements in biotechnology and pharmaceutical research, shaping the industry's landscape.

Collaborations: Desmet has collaborated closely with accomplished individuals in the field, including Ignace Lasters and Maria Henderikx. These collaborations have enriched the innovative process, leading to the development of cutting-edge technologies.

Conclusion: Johan Desmet's dedication to innovation and his pioneering work in biotechnology have left a lasting impact on the industry. His patents and inventions reflect his commitment to advancing scientific knowledge and finding novel solutions to complex challenges in the field.

This text is generated by artificial intelligence and may not be accurate.